Lynch Syndrome

specific

An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma. Patients often develop colorectal carcinomas at an early age (mean, 45 years). In the majority of the cases the lesions arise from the proximal colon. At the molecular level, high-frequency microsatellite instability is present.

75

Centers

96

Active Trials

$37M

Cancer Funding

Top Centers for Lynch Syndrome(75)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
86.8
282.6
3
NCI Comprehensive
High-Volume Research Center
81.6
4
NCI Comprehensive
Active Research Program
69.1
5
Active Research Program
67.6
6
Active Research Program
67.6
7
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
65.8
865.8
9
NCI Comprehensive
Active Research Program
65.1
10
NCI Comprehensive
Active Research Program
62.7
11
NCI Comprehensive
Active Research Program
62.5
12
NCI Comprehensive
Active Research Program
62.5
13
NCI Comprehensive
Active Research Program
62.5
14
Active Research Program
62.5
15
NCI Clinical
Active Research Program
62.5
16
Active Research Program
62.5
17
Active Research Program
62.5
18
Active Research Program
62.5
19
NCI Comprehensive
Active Research Program
61.8
20
NCI Comprehensive
Active Research Program
61.3
21
Active Research Program
59.9
22
NCI Comprehensive
Active Research Program
59.5
23
NCI Comprehensive
Active Research Program
59.0
2447.8
25
NCI Comprehensive
Active Research Program
46.4
26
NCI Comprehensive
Active Research Program
45.5
27
NCI Comprehensive
Active Research Program
44.6
28
NCI Comprehensive
Active Research Program
44.5
29
NCI Comprehensive
Active Research Program
44.5
30
NCI Comprehensive
Active Research Program
44.5
31
NCI Comprehensive
Active Research Program
44.5
32
NCI Comprehensive
Active Research Program
44.5
33
NCI Comprehensive
Active Research Program
44.5
34
NCI Comprehensive
Active Research Program
44.5
35
NCI Comprehensive
Active Research Program
44.5
36
NCI Comprehensive
Active Research Program
44.5
37
NCI Comprehensive
Active Research Program
44.5
38
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
44.5
39
NCI Comprehensive
Active Research Program
44.5
40
NCI Comprehensive
Active Research Program
44.5
41
NCI Comprehensive
Active Research Program
44.5
42
NCI Comprehensive
Active Research Program
44.5
43
NCI Comprehensive
Active Research Program
44.5
44
NCI Comprehensive
Active Research Program
44.5
45
NCI Comprehensive
Active Research Program
44.5
46
NCI Comprehensive
Active Research Program
44.5
47
NCI Clinical
Active Research Program
44.5
48
NCI Comprehensive
Active Research Program
44.5
49
Active Research Program
44.5
50
NCI Comprehensive
Active Research Program
44.5
51
NCI Comprehensive
Active Research Program
44.5
52
NCI Comprehensive
Active Research Program
44.5
53
NCI Comprehensive
Active Research Program
44.5
54
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
44.5
55
NCI Clinical
Active Research Program
44.5
56
NCI Comprehensive
Active Research Program
44.5
57
Active Research Program
44.5
58
NCI Comprehensive
Active Research Program
44.5
5944.5
60
Active Research Program
44.5
61
Active Research Program
44.5
62
Active Research Program
44.5
63
NCI Basic_laboratory
Active Research Program
44.5
64
Active Research Program
44.5
65
Active Research Program
44.5
66
Active Research Program
44.5
67
Active Research Program
44.5
68
Active Research Program
44.5
69
Active Research Program
44.5
70
Active Research Program
44.5
71
Active Research Program
44.5
72
NCI Comprehensive
Active Research Program
43.2
73
NCI Comprehensive
Active Research Program
42.7
7426.8
75
BC CancerVancouver, BC
26.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →